RXO, Inc. Annual Deferred Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
RXO, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • RXO, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$7M.
  • RXO, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$8M, a 60% increase from 2022.
  • RXO, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$20M, a 767% decline from 2021.
  • RXO, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $3M.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$8M +$12M +60% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-13
2022 -$20M -$23M -767% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-13
2021 $3M +$12M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-13
2020 -$9M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.